ÂÜÀòÂÒÂ×

Bob serves clients within the firm’s Finance & Accounting Optimization practice. He has proven expertise in budgeting, forecasting, complex modelling and big data, and especially deep experience in the pharmaceutical sector.

Before joining Virtas, he served clients as an independent consultant, including as the CFO of a private specialty pharmaceutical company and as CFO/COO/CIO of another specialty pharma company. He also had supported the Finance organization for the U.S. subsidiary of a major European biopharmaceutical company. Earlier in his career, Bob led revenue forecasting and analysis activities at Mylan for EpiPen® and other branded products. His earlier roles included asset manager for a NYSE-listed infrastructure company and Director, Corporate Development & Investor Relations for a NYSE-listed pharma development company. He previously worked at two investment banks after starting his career at Mobil Oil.

Bob has an MBA from Columbia University and a PhD in chemical engineering from the University of Notre Dame, and a bachelors in chemical engineering from Massachusetts Institute of Technology.